WOUND MANAGEMENT TECHNOLOGIES, INC. Uncategorized Contracts & Agreements

Description of Securities (Filed With SEC on March 30, 2021)

First Amendment of Sublicense Agreement, dated May 31, 2019, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

Second Amendment of Sublicense Agreement, dated January 26, 2021, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

Sublicense Agreement, dated August 27, 2018, between Cellerate, LLC, as Sublicensee, and CGI Cellerate RX, LLC, as Sublicensor (Filed With SEC on February 1, 2021)

Sublicense Agreement dated August 27, 2018 between CGI Cellerate RX, LLC and Cellerate, LLC (Filed With SEC on November 14, 2018)

Cellerate, LLC Statement of Operations for the month ending September 30, 2018 (Filed With SEC on November 14, 2018)

Letter Agreement dated April 26, 2016 by and between the Company, Evolution Venture Partners, LLC and Middlebury Securities, LLC (Filed With SEC on May 2, 2016)

Amendment to Letter of Intent (Filed With SEC on November 14, 2013)

BROOKHAVEN MEDICAL, INC. 11 Paces West Drive, N.W. Atlanta, Georgia 30327 404-467-9746 (Filed With SEC on October 15, 2013)

Amendment A to Manufacturer Exclusive Distributor Agreement, dated August 7, 2013 (Filed With SEC on October 2, 2013)

Amendment B to Manufacturer Exclusive Distributor Agreement, dated October 1, 2013 (Filed With SEC on October 2, 2013)

Manufacturer Exclusive Distributor Agreement dated June 21, 2013 (Filed With SEC on July 8, 2013)

COMMITMENT LETTER July 10, 2012 (Filed With SEC on July 19, 2012)

EXHIBIT 10.2 (Filed With SEC on November 30, 2011)

VERISCRIP ROYALTY AGREEMENT (Filed With SEC on February 9, 2010)

ROYALTY AGREEMENT (Filed With SEC on October 2, 2009)

Manufacturing Agreement dated as of November 28, 2007, by and between Wound Care Innovations, L.L.C. and Applied Nutritionals, LLC (Filed With SEC on November 30, 2007)